Streptococcal infection
MONDO:0021680Any of the several infectious disorders caused by members of streptococcus, a genus of gram positive bacteria belonging to the family Streptococcaceae. Streptococcal infections are classified into Groups A, B, C, D and G.
Also known as: Streptococcus caused disease or disorder, Streptococcus disease or disorder, Streptococcus infectious disease, streptococcal infection, infection, streptococcal, infections, streptococcal
132 clinical trials for this condition and its sub-types, 19 tagged with Streptococcal infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Streptococcal infection
-
Pneumococcal infection 90 trials · 100 incl. sub-types
3 sub-types
- Streptococcal pneumonia 16 trials
- Pneumococcal meningitis 0 trials
- Streptococcus pneumoniae discitis 0 trials
-
Group B streptococcal infection 9 trials
-
Streptococcal sore throat 8 trials
-
Impetigo 5 trials
2 sub-types
- Ecthyma 0 trials
- Impetigo herpetiformis 0 trials
-
Erysipelas 1 trial
-
Scarlet fever 0 trials
-
Streptococcal meningitis 0 trials
1 sub-type
- Pneumococcal meningitis 0 trials
-
Could a vaccine shield newborns from a deadly bacterial infection?
Vaccine CompletedThis study tests an experimental vaccine called GBS-NN/NN2 against Group B Streptococcus (GBS), a bacteria that can cause serious infections in newborns. The trial includes pregnant women both with and without HIV, giving two doses between 26 and 30 weeks of pregnancy. Researcher…
Phase 2 • Sponsor: Minervax ApS • Aim: Vaccine
Last updated Jul 16, 2026 00:00 UTC
-
New vaccine targets group b strep in seniors
Vaccine CompletedThis early-stage trial tested a new vaccine against Group B Streptococcus (GBS) in 90 healthy adults aged 55 to 75. Participants received three doses of the vaccine or a placebo, and researchers monitored safety and immune response for six months. The goal is to see if the vaccin…
Phase 1 • Sponsor: Minervax ApS • Aim: Vaccine
Last updated Jun 26, 2026 13:27 UTC
-
New vaccine AFX3772 aims to shield infants from pneumonia
Prevention CompletedThis study tested a new vaccine called AFX3772 in healthy infants about 2 months old. The goal was to see if it is safe and triggers a strong immune response against pneumococcal bacteria, which can cause pneumonia and other serious infections. Researchers compared AFX3772 with e…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
Are hidden immune defects causing your recurring infections? new study investigates.
Knowledge-focused CompletedThis study looked for hidden immune system problems in adults who get frequent or severe bacterial infections, like pneumonia or meningitis. Researchers screened 120 adults aged 18-65 to see how many had an undiagnosed primary immunodeficiency. The goal was to find out if these c…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists deliberately give volunteers strep throat to speed up vaccine development
Knowledge-focused CompletedThis completed early-phase study tested a new way to study Strep A bacteria, which causes strep throat and can lead to serious heart disease. Researchers safely exposed 40 healthy adults aged 18-40 to a specific strain of Strep A under controlled conditions. The goal was to see h…
Early phase 1 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Pandemic measures linked to drop then surge in severe strep a in kids
Knowledge-focused CompletedThis study looked at how the COVID-19 pandemic and related measures like lockdowns and mask-wearing affected severe Group A Strep infections in children in Paris. Researchers reviewed medical records of 269 children under 18 admitted to a Paris hospital between 2018 and 2023. The…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:07 UTC